In this episode, we explore the potential of fish oil as an adjunct to cognitive–behavioral therapy for treating depression in youth. Can this combination enhance treatment outcomes, or is cognitive–behavioral therapy alone just as effective? Join us as we dive into this intriguing study.

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 16
• Is Fish Oil Effective in Youth Depression?

In this episode, we explore the use of benzodiazepines and nonbenzodiazepine hypnotics for managing insomnia in major depressive disorder. How do these medications work, and what are the key considerations when prescribing them? Join us as we navigate the complexities of pharmacologic interventions for insomnia.

Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Pharmacologic Interventions for Insomnia: Benzodiazepines and Non-Benzodiazepine Hypnotics

In this episode, we explore the safety of antipsychotics in patients with liver disease. How can psychiatrists navigate the risk–benefit balance when treating medically complex individuals? Dr. Sydney LeFay discusses key insights from a recent review article, guiding antipsychotic selection and monitoring.

Faculty: Sydney LeFay, D.O. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.75 CMEs: Quick Take Vol. 56
• Antipsychotic Safety in Liver Disease

In this episode, we explore the complex relationship between insomnia and major depressive disorder. How does insomnia impact the course and treatment of depression? Join us as we dive into the neurobiology and clinical implications of this fascinating topic with expert Dr. Amit Chopra.

Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management
• Understanding the Relationship Between Insomnia Disorder and MDD

In this episode, we explore the long-term effects of ADHD medication use during pregnancy on children's development. Can continuing treatment pose risks, or is it safer than previously thought? Join us as we dive into a groundbreaking Danish study that sheds light on this critical question.

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: CAP Smart Takes Vol. 16
• In Utero Exposure to ADHD Medication and Long-Term Offspring Outcomes

In this episode, we explore the growing evidence for nonpharmacologic therapies in managing fibromyalgia symptoms. Could a combination of exercise, cognitive–behavioral therapy, and integrative approaches, like acupuncture or yoga, be the key to better outcomes for patients resistant to traditional treatments?

Faculty: Daniel Clauw, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia
• Nonpharmacologic Therapies for Fibromyalgia

In this episode, the editorial team of the Psychopharmacology Institute discusses 3 important topics presented at the APA Annual Meeting: Prescribing psychiatric medications during pregnancy, recent advances in clozapine treatment, and managing eating disorders, namely anorexia nervosa and bulimia nervosa. The episode covers the safety and dose adjustments for medications like SSRIs, lamotrigine, and lithium during pregnancy; early initiation and monitoring of clozapine; and effective treatments, including psychotherapy, olanzapine, and fluoxetine for eating disorders.

Hosts: Flavio Guzman, M.D., Paz Badia, M.D., and Lorena Rodriguez, M.D.

In this episode, we discuss a new study on maternal depression, antidepressant use, and pregnancy complications. Can antidepressants during pregnancy harm the baby? Dr. Lauren Osborne helps us weigh the risks and benefits.

Faculty: Lauren Osborne, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CMEs: Quick Take Vol. 56
• Neonatal and Pregnancy Complications Following Maternal Depression or Antidepressant Exposure

In this episode, we explore the most effective pharmacologic treatments for fibromyalgia, a complex nociplastic pain syndrome. Dr. Daniel Clauw shares his insights on the top drug classes for managing fibromyalgia and discusses why opioids should be avoided. Could the hyperactive endogenous opioid system in fibromyalgia patients explain the ineffectiveness of opioids?

Faculty: Daniel Claw, M.D. Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Nociplastic Pain Syndromes: Focus on Fibromyalgia
• Pharmacologic Therapies for Fibromyalgia

In this episode, we explore the use of antipsychotic medication in treating children and adolescents with anorexia nervosa. Can these medications play a role in promoting weight gain and reducing comorbid symptoms? Or do the risks outweigh the potential benefits in this vulnerable population?

Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: CAP Smart Takes Vol. 15
• Antipsychotics in the Treatment of Youth With Anorexia Nervosa